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I.   Executive Summary and Overall Evaluation 
 
The 2014 Bone and Muscle Risks Standing Review Panel (from here on referred to as the SRP) 
met for a site visit in Houston, TX on December 17 - 18, 2014.  The SRP reviewed the updated 
Evidence Reports for the Risk of Impaired Performance Due to Reduced Muscle Mass, Strength 
and Endurance and (from here on referred to as the 2014 Muscle Evidence Report) and the Risk 
of Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity (from here on 
referred to as the 2014 Aerobic Evidence Report), as well as the Research Plans for these Risks.  
The SRP agreed the Evidence Reports were comprehensive and described a logical sequence of 
steps taken by NASA and the scientific community to address the risk of impaired performance 
as a result of muscle atrophy, i.e., reduced muscle mass, loss of strength and loss of endurance in 
a microgravity environment.  The interdependence of the three physiological systems represented 
by this SRP (i.e., skeletal, muscular and cardiovascular) supports a level of discussion on system 
integration that is now appreciated by the Chief Scientist of the Human Research Program 
(HRP). 
 
The Evidence Reports cover the effects of microgravity on muscle, ranging from the cellular and 
molecular levels to whole muscle function.  The reports also addressed other factors related to 
muscle (e.g., neural influences, insulin resistance, heat stress, and nutrition) that will serve as a basis 
for future discussions on the integration of physiological systems and the response to microgravity.  
The SRP agreed the Evidence Reports were balanced, provided insight to muscle function, and 
laid the foundation for the integrated approach now taken by the SRP. 
 
II. Review of the Evidence for the Risk of Impaired Performance Due to 
Reduced Muscle Mass, Strength and Endurance 
 
1.  Evaluate the 2014 Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and 
Endurance (Muscle) Evidence Report using the following criteria: 
 
A. Does the 2014 Evidence Report provide sufficient evidence that the Risk is relevant to 
long-term space missions? 
 
The SRP agrees that the 2014 Muscle Evidence Report provides sufficient documentation in 
support of the position that the Risk is relevant to long-term space missions.  The 2014 
Muscle Evidence Report emphasizes the use of appropriate countermeasure programs that 
employ informed physical exercise interventions, including aerobic and resistance exercise.  
For example, a discussion that continues today revolves around the statement “load 
capacities for resistance exercise devices for use in space must be able to replace the body 
loads that are lost in microgravity on top of the normal loads that one would use on the 
ground.”  The idea that high resistance loads are requisite to attenuate muscle atrophy is one 
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currently supported by the SRP.  Noted in the 2014 Muscle Evidence Report, however, and a 
current serious challenge to the use of optimal exercise equipment on the International Space 
Station (ISS) is the lack of availability of current hardware on the ISS for use in the exercise 
interventions.  The 2014 Muscle Evidence Report states, and the SRP agrees, that this 
situation will have a very negative impact on the maintenance of crew health and physical 
fitness on the ISS.  While the evidence is clear and strongly supports the use of exercise 
countermeasures the 2014 Muscle Evidence Report also states “access to the crew members 
during both short and long-term missions to study the efficacy of the proposed 
countermeasures has been limited.”  This remains a challenge today. 
 
Additionally, the 2014 Muscle Evidence Report states “to comprehensively assess this risk, 
i.e., muscle atrophy, we must fully define mission-specific functional tasks and develop 
countermeasures to address those task demands.”  This remains a major concern of the SRP, 
i.e., defining specific task demands. 
 
B. Are the Risk Title and Statement properly stated in the current version of the HRP 
Integrated Research Plan (IRP)?* 
 
The SRP thinks the Risk Title in the current version of the IRP is appropriate.  The SRP 
thinks the wording of the Risk Title in the current version of the IRP is appropriate, but the 
new wording presented at the meeting (page 4 of the Muscle presentation) was not. 
 
C. Is the text of the Risk Context provided in the HRP IRP clear? 
 
The SRP suggests rewording the Risk Content to (suggested edits in bold and strikethrough):  
There is a growing body of research evidence that indicates skeletal muscles, particularly 
muscles of the lower limb, undergo atrophy and structural and metabolic alterations during 
spaceflight.  However, the associations between in-flight exercise, muscle changes, and 
performance levels are not well understood.  Efforts should be made to understand the 
current status of pre-flight, in-flight, and post-flight exercise performance capability and 
what goals/target areas for protection are needed for the in-flight exercise program.  Pre-
flight data are critical and should be included where possible to be more informative. 
 
D. Does the evidence base make the case for the knowledge-type gaps presented? 
 
Yes.  The section of the 2014 Muscle Evidence Report on Human Ground-Based Evidence 
presents an excellent overview of the various models, such as bed rest, not only addressing 
the common element of a rapid loss and reduced but continued decrements in muscle volume 
in microgravity, but also the psychological adjustments that exacerbate physiological 
stressors.  Additionally, the nutritional factors, such as nutritional inadequacies/less energy 
intake, that influence decreases in muscle mass were discussed.  Women seem to lose muscle 
volume at a slightly faster rate than men, but the data on this potentially important sex 
difference are rather sparse. 
 
Finally, the 2014 Muscle Evidence Report outlines several content-related areas that should 
be considered when discussing muscle function and the challenges in microgravity to 
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maintain muscle mass and muscle strength.  Neural influences, muscle protein synthesis, 
changes in muscle fibers and enzyme activity, insulin resistance and heat 
stress/thermoregulation are all discussed and summarized along with a discussion of 
appropriate human and animal models for use as surrogate models for the human experience 
in space. 
 
E. Are there any additional knowledge-type gaps that should be considered for this specific 
Risk? 
 
The SRP does not think there are any additional knowledge-type gaps that should be 
considered at this time. 
 
F. Does the Evidence Report address relevant interactions between this Risk and others in 
the HRP IRP? 
 
The 2014 Muscle Evidence Report does address relevant interactions between the Muscle 
Risk and others in the HRP IRP.  The muscle response to microgravity was studied in detail 
with respect to fiber types (muscle quality), motor unit function, morphology, size, and 
mechanical output (e.g., power production), but more summary statements were needed 
“along the way.”  There is no integration of muscle function with either bone or the central 
nervous system.  The newly formed emphasis on integration of information, while still a 
challenge to the HRP, is strongly supported by the SRP. 
 
G. Are the qualifications of the author(s) appropriate for identifying the evidence base 
necessary to characterize the given Risk? 
 
Yes, the team of authors is knowledgeable and qualified. 
 
H. Is there information from other HRP disciplines that need to be included in the 2014 
Evidence Report? 
 
The SRP does not think additional information from other HRP disciplines is needed at this 
time.  The 2014 Muscle Evidence Report covers a great deal of information and does review 
related areas in Section B. 
 
I. Is the breadth of the cited literature sufficient? 
 
Yes, the 2014 Muscle Evidence Report cites all relevant studies/literature published over the 
past four to five decades providing an excellent review on the effect of microgravity on 
skeletal muscle from the level of molecules and cells to the level of whole muscle and its’ 
ability to perform tasks requisite to successful missions in space. 
 
J. What is the overall quality and readability of the 2014 Evidence Report? 
 
The overall quality and readability of the 2014 Muscle Evidence Report is good.  
Organization of the 2014 Muscle Evidence Report indicates strong progress in developing 
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questions informed by actual data, albeit limited, from the Mercury to the Apollo Programs, 
Skylab and subsequently the Space Shuttle program and the ISS.  New technologies were 
created to study muscle response to microgravity and selected exercise countermeasures. 
 
2. Provide comments on any important issues that are not covered by the criteria in #1 above. 
 
The 2014 Muscle Evidence Report is comprehensive and reasonably complete.  Indeed, the 
2014 Muscle Evidence Report may well serve as a basis for the SRP’s continued discussion 
regarding the integration of evidence produced by all SRPs and the generation of the next 
level of hypotheses needed to study the integration of physiological systems in response to 
the challenges of microgravity. 
 
III. Review of the Evidence for the Risk of Reduced Physical Performance 
Capabilities Due to Reduced Aerobic Capacity 
 
1.  Evaluate the 2014 Risk of Reduced Physical Performance Capabilities Due to Reduced 
Aerobic Capacity (Aerobic) Evidence Report using the following criteria: 
 
A. Does the 2014 Evidence Report provide sufficient evidence that the Risk is relevant to 
long-term space missions? 
 
Yes, the SRP thinks the 2014 Aerobic Evidence Report provides sufficient evidence that the 
Risk is relevant to long-term space missions. 
 
B. Are the Risk Title and Statement properly stated in the current version of the HRP 
Integrated Research Plan (IRP)?* 
 
The Risk Title is appropriate in the current version of the IRP.  The SRP suggests rewording 
the Risk Statement to (suggested edit in bold):  Given the condition of reduced aerobic 
capacity as measured by VO2 max/peak, there is a possibility of reduced physical 
performance. 
 
C. Is the text of the Risk Context provided in the HRP IRP clear? 
 
The SRP suggests rewording the Risk Content to (suggested edits in bold and strikethrough):  
Astronauts’ physical performance during a mission, including activity in microgravity and 
fractional gravity, is critical to mission success.  Setting minimum fitness standards VO2 
standards (ml/kg) and measuring whether crew can maintain these standards will document 
the effectiveness of maintenance regimens. 
 
D. Does the evidence base make the case for the knowledge-type gaps presented? 
 
The SRP thinks the evidence base in the 2014 Aerobic Evidence Report makes the case for 
the knowledge-type gaps presented. 
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E. Are there any additional knowledge-type gaps that should be considered for this specific 
Risk? 
 
The SRP does not think there are any additional knowledge-type gaps that should be 
considered at this time. 
 
F. Does the Evidence Report address relevant interactions between this Risk and others in 
the HRP IRP? 
 
The SRP thinks the 2014 Aerobic Evidence Report addresses relevant interactions, but this 
could be improved as mentioned by the Integration Panel discussion. 
 
G. Are the qualifications of the author(s) appropriate for identifying the evidence base 
necessary to characterize the given Risk? 
 
Yes, the team of authors is knowledgeable and qualified. 
 
H. Is there information from other HRP disciplines that need to be included in the 2014 
Evidence Report? 
 
The SRP does not think additional information from other HRP disciplines is needed at this 
time. 
 
I. Is the breadth of the cited literature sufficient? 
 
The SRP thinks the breadth of the cited literature in the 2014 Aerobic Evidence Report is 
sufficient. 
 
J. What is the overall quality and readability of the 2014 Evidence Report? 
 
The overall quality and readability of the 2014 Aerobic Evidence Report is good. 
 
2.  Provide comments on any important issues that are not covered by the criteria in #1 above.  
 
The SRP has no additional comments at this time.
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IV. 2014 Bone and Muscle Risks SRP Evidence Review: Statement of Task 
for the Risk of Impaired Performance Due to Reduced Muscle Mass, 
Strength and Endurance (Muscle) and the Risk of Reduced Physical 
Performance Capabilities Due to Reduced Aerobic Capacity (Aerobic) 
 
In 2008, the Institute of Medicine (IOM) reviewed NASA’s Human Research Program (HRP) 
Evidence Books that describe the Risks that were identified in NASA's Human Research 
Program Requirements Document (PRD).  The 2014 Evidence Reports for the Risk of Impaired 
Performance Due to Reduced Muscle Mass, Strength and Endurance (Muscle) and the Risk of 
Reduced Physical Performance Capabilities Due to Reduced Aerobic Capacity (Aerobic) have 
not been reviewed since the last IOM review and there have been significant changes to the 
evidence base for the Risks. 
 
The 2014 Bone and Muscle Risks Standing Review Panel (SRP) is chartered by the Human 
Research Program (HRP) Chief Scientist to review the Evidence Reports for the Muscle and 
Aerobic Risks.  The 2014 Bone and Muscle Risks SRP will evaluate the Evidence Reports and 
generate a final report of your analyses of the evidence base, including any recommendations on 
how to improve the current Evidence Report, and submit it to the HRP Chief Scientist.  Your 
report will also be made available on the Human Research Roadmap (HRR) website. 
 
The 2014 Bone and Muscle Risks SRP is charged to: 
1. Separately evaluate the 2014 Muscle and Aerobic Evidence Reports based on each of the 
following criteria: 
A. Does the 2014 Evidence Report provide sufficient evidence that the Risk is relevant to 
long-term space missions? 
B. Are the Risk Title and Statement properly stated in the current version of the HRP 
Integrated Research Plan (IRP)?* 
C. Is the text of the Risk Context provided in the HRP IRP clear?* 
D. Does the evidence base make the case for the knowledge-type gaps presented? 
E. Are there any additional knowledge-type gaps that should be considered for this specific 
Risk? 
F. Does the Evidence Report address relevant interactions between this Risk and others in 
the HRP IRP? 
G. Are the qualifications of the author(s) appropriate for identifying the evidence base 
necessary to characterize the given Risk? 
H. Is there information from other HRP disciplines that need to be included in the 2014 
Evidence Report? 
I. Is the breadth of the cited literature sufficient? 
J. What is the overall quality and readability of the 2014 Evidence Report? 
 
2. Provide comments on any important issues that are not covered by the criteria in #1 above. 
 
* Please be aware that any suggested changes to the Risk Title, Statement, and Risk Context by the SRP may need to 
be approved by the Human Systems Risk Board (HSRB).  The HSRB has the overall responsibility to implement and 
maintain a consistent, integrated process for assessing, documenting, and tracking all risks to the human system 
associated with spaceflight activities (both in flight and post flight). 
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Additional information regarding this review: 
 
1. Attend a meeting in Houston, TX on December 17 - 18, 2014 to discuss the Evidence Report 
with the Human Health Countermeasures (HHC) Element.  At this meeting, prepare a draft 
report for each risk that addresses each of the evaluation criteria listed in the panel charge (A-
J) including any recommendations on how to improve the Evidence Report.  Debrief the 
HRP Chief Scientist and a representative from the HHC Element on the salient points that 
will be included in the final report and specifically the items in the panel charge. 
 
2. Prepare a draft final report for each risk (within one month of the site visit debrief) that 
contains a detailed evaluation of the Evidence Report specifically addressing items #1 and #2 
of the SRP charge.  The draft final report will be sent to the HRP Chief Scientist and he will 
forward it to the appropriate Element for their review.  The HHC Element and the HRP Chief 
Scientist will review the draft final report and identify any misunderstandings or errors of 
fact and then provide official feedback to the SRP within two weeks of receipt of the draft 
report.  If any misunderstandings or errors of fact are identified, the SRP will be requested to 
address them and finalize the 2014 SRP Final Report as quickly as possible.  The 2014 SRP 
Final Report will be submitted to the HRP Chief Scientist and copies will be provided to the 
HHC Element that sponsors the muscle and aerobic disciplines and also made available to the 
other HRP Elements.  The 2014 SRP Final Report will be made available on the HRR 
website (http://humanresearchroadmap.nasa.gov/). 
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To clarify, the Risk Statement and Risk Context are defined as follows: 
 
Risk Statement: 
“Given the CONDITION, there is a possibility that a CONSEQUENCE will occur”. 
 
Condition:  a single phrase briefly describing current key circumstances, situations, etc., 
that are causing concern, doubt, anxiety, or uncertainty – something that keeps you up at 
night. 
 
Consequence:  a single phrase or sentence that describes the key, negative outcome(s) of 
the current conditions. 
 
Notes:  
The condition-consequence format provides a more complete picture of the Risk, which 
is critical during mitigation planning.  The condition component focuses on what is 
currently causing concern.  This is something that is true or widely perceived to be true.  
This component provides information that is useful when determining how to mitigate a 
Risk. 
 
The consequence component focuses on the intermediate and long-term impact of the 
risk.  Understanding the depth and breadth of the impact is useful in determining how 
much time, resources, and effort should be allocated to the mitigation effort. 
 
A well-formed Risk Statement usually has only one condition, and has one or more 
consequences. 
 
Risk Context: 
Purpose:  provide enough additional information about the Risk to ensure that the original 
intent of the Risk can be understood by other personnel, particularly after time has 
passed. 
 
Description:  capture additional information regarding the circumstances, events, and 
interrelationships not described in the Risk Statement. 
 
An effective context captures the what, when, where, how, and why of the Risk by 
describing the circumstances, contributing factors, and related issues (background and 
additional information that are NOT in the Risk Statement). 
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